Researchers used a cross-vaccination strategy in the trial, which involved 33 healthy adult volunteers between the ages of 21 and 45.
The work explains how lipocartilage cells form and preserve their own lipid reservoirs while maintaining a consistent size.
More potent AI models and the amassing of vast amounts of cell data in recent years are beginning to turn biology into a more predictive science.
Scientists created new medications to suppress PD-1 and activate the body’s immune system to combat cancer after its discovery.
Researchers have developed a new method to detect more contagious forms of bacteria or viruses that transmit to people, such as those that cause TB, whooping cough, COVID, and the flu.
As 2024 is finishing off, this year witnessed some major science research, clinical trials, and setbacks. From the last year onwards we started the turnback to review major scientific events of the year. The first news we published in 2024 was about “Healthy brains may depend on a common marker […]
Although AI and quantum computing have simplified the process of designing tiny molecules for medicinal therapy, this has resulted in the need for far quicker techniques to verify the effectiveness of novel medications.
The recovery process for patients with acute spinal cord injuries can be enhanced by antibodies. This has been studied with encouraging results by researchers at 13 clinics in Germany, Switzerland, the Czech Republic, and Spain. For the first time, patient groups exhibiting a treatment impact that was clinically relevant could be identified. December 2024 will see the start of a follow-up study.
S. aureus colonizes most of us during infancy and travels through our nasal passages. It doesn’t hurt us most of the time.
In addition to confirming viral methyltransferases as a viable therapeutic target, the results imply that Tuschl’s specific inhibitor would have few adverse effects.
